176 related articles for article (PubMed ID: 28796261)
1. p53-R273H upregulates neuropilin-2 to promote cell mobility and tumor metastasis.
Lv T; Wu X; Sun L; Hu Q; Wan Y; Wang L; Zhao Z; Tu X; Xiao ZJ
Cell Death Dis; 2017 Aug; 8(8):e2995. PubMed ID: 28796261
[TBL] [Abstract][Full Text] [Related]
2. Hotspot mutant p53-R273H inhibits KLF6 expression to promote cell migration and tumor metastasis.
Sun S; Chen H; Sun L; Wang M; Wu X; Xiao ZJ
Cell Death Dis; 2020 Jul; 11(7):595. PubMed ID: 32733026
[TBL] [Abstract][Full Text] [Related]
3. p53-R273H promotes cancer cell migration via upregulation of neuraminidase-1.
Lv T; Lv H; Fei J; Xie Y; Lian D; Hu J; Tang L; Shi X; Wang J; Zhang S; Li F; Jiang X; Yi Y
J Cancer; 2020; 11(23):6874-6882. PubMed ID: 33123278
[TBL] [Abstract][Full Text] [Related]
4. An N
Uddin MB; Roy KR; Hosain SB; Khiste SK; Hill RA; Jois SD; Zhao Y; Tackett AJ; Liu YY
Biochem Pharmacol; 2019 Feb; 160():134-145. PubMed ID: 30578766
[TBL] [Abstract][Full Text] [Related]
5. Dlx homeobox genes promote cortical interneuron migration from the basal forebrain by direct repression of the semaphorin receptor neuropilin-2.
Le TN; Du G; Fonseca M; Zhou QP; Wigle JT; Eisenstat DD
J Biol Chem; 2007 Jun; 282(26):19071-81. PubMed ID: 17259176
[TBL] [Abstract][Full Text] [Related]
6. The activating transcription factor 3 protein suppresses the oncogenic function of mutant p53 proteins.
Wei S; Wang H; Lu C; Malmut S; Zhang J; Ren S; Yu G; Wang W; Tang DD; Yan C
J Biol Chem; 2014 Mar; 289(13):8947-59. PubMed ID: 24554706
[TBL] [Abstract][Full Text] [Related]
7. Gain-of-function mutant p53 upregulates CXC chemokines and enhances cell migration.
Yeudall WA; Vaughan CA; Miyazaki H; Ramamoorthy M; Choi MY; Chapman CG; Wang H; Black E; Bulysheva AA; Deb SP; Windle B; Deb S
Carcinogenesis; 2012 Feb; 33(2):442-51. PubMed ID: 22114072
[TBL] [Abstract][Full Text] [Related]
8. P53-R273H mutation enhances colorectal cancer stemness through regulating specific lncRNAs.
Zhao Y; Li Y; Sheng J; Wu F; Li K; Huang R; Wang X; Jiao T; Guan X; Lu Y; Chen X; Luo Z; Zhou Y; Hu H; Liu W; Du B; Miao S; Cai J; Wang L; Zhao H; Ying J; Bi X; Song W
J Exp Clin Cancer Res; 2019 Aug; 38(1):379. PubMed ID: 31455383
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of glucosylceramide synthase eliminates the oncogenic function of p53 R273H mutant in the epithelial-mesenchymal transition and induced pluripotency of colon cancer cells.
Hosain SB; Khiste SK; Uddin MB; Vorubindi V; Ingram C; Zhang S; Hill RA; Gu X; Liu YY
Oncotarget; 2016 Sep; 7(37):60575-60592. PubMed ID: 27517620
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver.
Gray MJ; Van Buren G; Dallas NA; Xia L; Wang X; Yang AD; Somcio RJ; Lin YG; Lim S; Fan F; Mangala LS; Arumugam T; Logsdon CD; Lopez-Berestein G; Sood AK; Ellis LM
J Natl Cancer Inst; 2008 Jan; 100(2):109-20. PubMed ID: 18182619
[TBL] [Abstract][Full Text] [Related]
11. p53 dominant-negative mutant R273H promotes invasion and migration of human endometrial cancer HHUA cells.
Dong P; Tada M; Hamada J; Nakamura A; Moriuchi T; Sakuragi N
Clin Exp Metastasis; 2007; 24(6):471-83. PubMed ID: 17636407
[TBL] [Abstract][Full Text] [Related]
12. Mutant p53 increases exosome-mediated transfer of miR-21-3p and miR-769-3p to promote pulmonary metastasis.
Ju Q; Zhao L; Gao J; Zhou L; Xu Y; Sun Y; Zhao X
Chin J Cancer Res; 2019 Jun; 31(3):533-546. PubMed ID: 31354222
[TBL] [Abstract][Full Text] [Related]
13. Neuropilin-2 promotes growth and progression of papillary thyroid cancer cells.
Lee G; Kang YE; Oh C; Liu L; Jin Y; Lim MA; Won HR; Chang JW; Koo BS
Auris Nasus Larynx; 2020 Oct; 47(5):870-880. PubMed ID: 32381353
[TBL] [Abstract][Full Text] [Related]
14. Mutant TP53 G245C and R273H promote cellular malignancy in esophageal squamous cell carcinoma.
Kang N; Wang Y; Guo S; Ou Y; Wang G; Chen J; Li D; Zhan Q
BMC Cell Biol; 2018 Aug; 19(1):16. PubMed ID: 30126368
[TBL] [Abstract][Full Text] [Related]
15. Mutant p53 on the Path to Metastasis.
Tang Q; Su Z; Gu W; Rustgi AK
Trends Cancer; 2020 Jan; 6(1):62-73. PubMed ID: 31952783
[TBL] [Abstract][Full Text] [Related]
16. Preferred binding of gain-of-function mutant p53 to bidirectional promoters with coordinated binding of ETS1 and GABPA to multiple binding sites.
Vaughan CA; Deb SP; Deb S; Windle B
Oncotarget; 2014 Jan; 5(2):417-27. PubMed ID: 24481480
[TBL] [Abstract][Full Text] [Related]
17. A gain-of-function senescence bypass screen identifies the homeobox transcription factor DLX2 as a regulator of ATM-p53 signaling.
Wang Y; Xu Q; Sack L; Kang C; Elledge SJ
Genes Dev; 2016 Feb; 30(3):293-306. PubMed ID: 26833729
[TBL] [Abstract][Full Text] [Related]
18. Neuropilin-2 promotes melanoma growth and progression in vivo.
Moriarty WF; Kim E; Gerber SA; Hammers H; Alani RM
Melanoma Res; 2016 Aug; 26(4):321-8. PubMed ID: 26881875
[TBL] [Abstract][Full Text] [Related]
19. Expression of Neuropilin-2 in salivary adenoid cystic carcinoma: its implication in tumor progression and angiogenesis.
Cai Y; Wang R; Zhao YF; Jia J; Sun ZJ; Chen XM
Pathol Res Pract; 2010 Dec; 206(12):793-9. PubMed ID: 20851535
[TBL] [Abstract][Full Text] [Related]
20. Gain-of-Function Mutant p53 R273H Interacts with Replicating DNA and PARP1 in Breast Cancer.
Xiao G; Lundine D; Annor GK; Canar J; Ellison V; Polotskaia A; Donabedian PL; Reiner T; Khramtsova GF; Olopade OI; Mazo A; Bargonetti J
Cancer Res; 2020 Feb; 80(3):394-405. PubMed ID: 31776133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]